Summary
WiseGuyReports.com adds “Cancer Immunotherapies Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.
Cancer immunotherapy, also called biologic therapy, which can predominantly be classed as a form of targeted therapy, It is designed to stimulate the body’s immune system to attack tumours.
The global Cancer Immunotherapies market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cancer Immunotherapies market based on company, product type, end user and key regions.
This report studies the global market size of Cancer Immunotherapies in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Immunotherapies in these regions.
This research report categorizes the global Cancer Immunotherapies market by top players/brands, region, type and end user. This report also studies the global Cancer Immunotherapies market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen
AstraZeneca
Roche
Bristol-Myers Squibb
Bayer
Merck
ARMO BioSciences (Eli Lilly)
Novartis
Pfizer
Johnson & Johnson
AbbVie
Gilead Sciences
Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3925109-global-cancer-immunotherapies-market-insights-forecast-to-2025
Market size by Product
Monoclonal Antibodies (MABs)
Cancer Vaccines
Immunomodulators
Adoptive Cell transfer
Checkpoint Inhibitors
Market size by End User
Breast Cancer
Leukemia
Lymphoma
Melanoma
Colorectal Cancer
Non-Small Cell Lung Cancer
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cancer Immunotherapies market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cancer Immunotherapies market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cancer Immunotherapies companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cancer Immunotherapies submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cancer Immunotherapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
At Any Query @ https://www.wiseguyreports.com/enquiry/3925109-global-cancer-immunotherapies-market-insights-forecast-to-2025
Major Key Points in Table of Content
1 Study Coverage
1.1 Cancer Immunotherapies Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cancer Immunotherapies Market Size Growth Rate by Product
1.4.2 Monoclonal Antibodies (MABs)
1.4.3 Cancer Vaccines
1.4.4 Immunomodulators
1.4.5 Adoptive Cell transfer
1.4.6 Checkpoint Inhibitors
1.5 Market by End User
1.5.1 Global Cancer Immunotherapies Market Size Growth Rate by End User
1.5.2 Breast Cancer
1.5.3 Leukemia
1.5.4 Lymphoma
1.5.5 Melanoma
1.5.6 Colorectal Cancer
1.5.7 Non-Small Cell Lung Cancer
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Immunotherapies Market Size
2.1.1 Global Cancer Immunotherapies Revenue 2014-2025
2.1.2 Global Cancer Immunotherapies Sales 2014-2025
2.2 Cancer Immunotherapies Growth Rate by Regions
2.2.1 Global Cancer Immunotherapies Sales by Regions
2.2.2 Global Cancer Immunotherapies Revenue by Regions
….
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Business Overview
11.1.3 Amgen Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen Cancer Immunotherapies Products Offered
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 Company Business Overview
11.2.3 AstraZeneca Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.2.4 AstraZeneca Cancer Immunotherapies Products Offered
11.2.5 AstraZeneca Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.3 Roche Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Roche Cancer Immunotherapies Products Offered
11.3.5 Roche Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Company Business Overview
11.4.3 Bristol-Myers Squibb Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bristol-Myers Squibb Cancer Immunotherapies Products Offered
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Company Business Overview
11.5.3 Bayer Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bayer Cancer Immunotherapies Products Offered
11.5.5 Bayer Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Company Business Overview
11.6.3 Merck Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Merck Cancer Immunotherapies Products Offered
11.6.5 Merck Recent Development
11.7 ARMO BioSciences (Eli Lilly)
11.7.1 ARMO BioSciences (Eli Lilly) Company Details
11.7.2 Company Business Overview
11.7.3 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.7.4 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Products Offered
11.7.5 ARMO BioSciences (Eli Lilly) Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Novartis Cancer Immunotherapies Products Offered
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Company Business Overview
11.9.3 Pfizer Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Pfizer Cancer Immunotherapies Products Offered
11.9.5 Pfizer Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Company Business Overview
11.10.3 Johnson & Johnson Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Johnson & Johnson Cancer Immunotherapies Products Offered
11.10.5 Johnson & Johnson Recent Development
11.11 AbbVie
11.12 Gilead Sciences
Continued….
Contact Us: sales@wiseguyreports.com
Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/3925109-global-cancer-immunotherapies-market-insights-forecast-to-2025